1,3,5-Tris((trimethylsilyl)ethynyl)benzene, 97%, 1g

4-Nitrobenzyl chloride, min 98%, for synthesis, 50 g, glass packaging

N-[4-Morpholine-4-sulfonyl)phenyl]acetamide, 1g

methyl(methylimino)(phenyl)-lambda6-sulfanone, 95.0%, 500mg

4-Amino-3-nitrobenzoic Acid>95.0%(HPLC)(T)25g

Ethyl 4-(methylamino)-2-(methylsulfanyl)-5-pyrimidinecarboxylate, 95.0%, 10g

3-(Aminomethyl)-4-methoxy-6-methylpyridin-2(1H)-one hydrochloride, 98%, 100mg

2-((Tert-butoxycarbonyl)(ethyl)amino)-2-methylpropanoic acid, 98%, 25g

5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 100mg

2-Methoxyethyl Acrylate (stabilized with MEHQ)>98.0%(GC)25mL

1-[(tert-butoxy)carbonyl]-2-methylazetidine-3-carboxylic acid, 95.0%, 500mg

1-(3-Methoxypropyl)-1h-pyrazol-3-amine, 95%, 250mg

1-[(4-isopropylphenyl)sulfonyl]piperazine, 250mg